"Le Centre Hospitalier de Cornouaille vous accueille, 24h/24 et 7j/7, pour tous vos besoins de santé. Nous vous proposons des soins de tous types. Nos professionnels de santé sont là pour vous. Pour de plus amples informations, contactez le secrétariat de l'hôpital ou visitez notre site internet."

During the past decade, Centre Hospitalier de Cornouaille conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 2 clinical trials were completed, i.e. on average, 2.5% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 2 clinical trials were completed. i.e. 4.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Cornouaille" #1 sponsor was "University Hospital, Brest" with 36 trials, followed by "Nantes University Hospital" with 8 trials sponsored, "Rennes University Hospital" with 6 trials sponsored, "UNICANCER" with 4 trials sponsored and "Centre Hospitalier de Cornouaille" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Cornouaille" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Centre Hospitalier Régional et Universitaire de Brest" with 2 trials as a collaborator, "Groupe Français de Pneumo-Cancérologie" with 2 trials as a collaborator and "Janssen-Cilag Ltd." with 2 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Cornouaille" are "Breast Cancer" (3 trials), "Venous Thromboembolism" (3 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Corona Virus Infection" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Centre Hospitalier de Cornouaille" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Cornouaille" are "Drug" (44 trials), "Other" (20 trials), "Device" (7 trials), "Procedure" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Hydroxychloroquine" (3 trials), "Bevacizumab" (2 trials), "Rituximab" (2 trials) and "Vinorelbine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Cornouaille" are 86 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Cornouaille". undefined are not yet recruiting, 35 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Centre Hospitalier de Cornouaille, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Cornouaille, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".

Centre Hospitalier de Cornouaille has several departments that took part in Clinical trials: "Chi De Cornouaille; Oncologie Hospitalisation" - 3 trials, "CH QUIMPER - Service d'infectiologie" - 2 trials